Noninvasive can be used as a synonym for in situ, ICD-O-3 behavior code /2. The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. For example, 173.22:Squamous cell carcinoma of the skin of the ear and external auditory canal. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (, Intraepidermal squamous carcinoma of face, Squamous cell carcinoma in situ, skin of face. All Rights Reserved (or such other date of publication of CPT). Cancer in situ, skin of scalp The CMS.gov Web site currently does not fully support browsers with Example 1: A patient returns to the dermatologist to discuss removal of his SCC on his lower lip. The program covers drugs that are furnished "incident-to" a physician's service provided that the drugs are not "usually self-administered" by the patient. Local Coverage Articles are a type of educational document published by the Medicare Administrative Contractors (MACs). The Centers for Medicare & Medicaid Services (CMS), the federal agency responsible for administration of the Medicare, PDF Protocol for Identifying Cancers "JavaScript" disabled. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. C44.311 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. S. He is an alumnus of York College of Pennsylvania and Clemson University. Check out the dx block of D04.4. The redetermination process may be utilized for consideration of services performed outside of the reasonable and necessary requirements in the LCD. Vulval intraepithelial neoplasia (VIN). Squamous intraepithelial lesion Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT for resale and/or license, transferring copies of CDT to any party not bound by this agreement, creating any modified or derivative work of CDT, or making any commercial use of CDT. CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. Some articles contain a large number of codes. Notice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. Fv 27, 2023 . . The codes for squamous cell carcinoma are under category C44 Other and unspecified malignant neoplasm of skin. The AMA assumes no liability for data contained or not contained herein. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (, malignant neoplasm of skin of genital organs (, Primary malignant neoplasm of skin of breast. The 2023 edition of ICD-10-CM C44.52 became effective on October 1, 2022. PDF Updated 7 9 18 ICD-O-3 numeric table - NAACCR Get free rules, notes, crosswalks, synonyms, history for ICD-10 code C44.62. authorized with an express license from the American Hospital Association. you could code both and use the exclude 1 exception if documentation were to indicate invasive in one breast and in-situ in the other. If you do not agree with all terms and conditions set forth herein, click below on the button labeled "I do not accept" and exit from this computer screen. If malignant, any secondary (metastatic) sites should also be . The submitted medical record must support the use of the selected ICD-10-CM code(s). A federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services. Treatment can involve surgical and nonsurgical methods. Please do not use this feature to contact CMS. The 4.2 cm excised diameter lesion Medicaid and the State Children's Health Insurance Programs, contracts with certain organizations to assist in the administration The term carcinoma in situ (or CIS) . C44.229 Squamous cell carcinoma of skin of left ear and external auricular canal Squamous Cell Carcinoma (SCC) 31 Coding of Neoplasms in ICD-10-CM A patient returns to the dermatologist to discuss removal of his SCC on his lower lip. This email will be sent from you to the CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Squamous cell carcinoma, skin of left breast; Squamous cell carcinoma, skin of right breast; ICD-10-CM C44.521 is grouped within Diagnostic Related Group(s) (MS-DRG v 40.0): 606 Minor skin disorders with mcc; 607 Minor skin disorders without mcc; Convert C44.521 to ICD-9-CM. SCCs often occur on the sun-exposed areas of the body, such as the rim of the ear, lower lip, face, bald scalp, neck, hands, arms, and legs. PDF Appendix E1 - 2021 SEER Program Coding and Staging Manual Reportable Chemical exposures, such as arsenic in drinking water, tar, or working with insecticides or herbicides. Morphology & Grade | SEER Training - National Cancer Institute Proper coding is C44.622 Squamous cell carcinoma of skin of right upper limb, including shoulder. Earn CEUs and the respect of your peers. Differences between ICD-O & ICD-10 | SEER Training You can use the Contents side panel to help navigate the various sections. Usual type vulval intraepithelial neoplasia will not infringe on privately owned rights. Breast codes for ICD-10-CM include sex along with laterality. Stage 0 includes: tis, n0, m0. Basal cell carcinoma of skin, unspecified. All neoplasms are classified in this chapter, whether they are functionally active or not. Your MCD session is currently set to expire in 5 minutes due to inactivity. In accordance with CMS Ruling 95-1 (V), utilization of these services should be consistent with locally acceptable standards of practice. 5th digit 1: Basal cell carcinoma of skin 5th digit 2: Squamous cell carcinoma of skin 5th digit 9: Other specific malignant neoplasm of skin : Kaposi Sarcoma (46) . Billing and Coding articles provide guidance for the related Local Coverage Determination (LCD) and assist providers in submitting correct claims for payment. Instructions for enabling "JavaScript" can be found here. You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. Squamous cell carcinoma (80703; arises mostly in lower third of cervix; 90% of all cervical cancers; also called epidermoid carcinoma) Squamous carcinoma in situ with questionable stromal invasion (80762) Organizations who contract with CMS acknowledge that they may have a commercial CDT license with the ADA, and that use of CDT codes as permitted herein for the administration of CMS programs does not extend to any other programs or services the organization may administer and royalties dues for the use of the CDT codes are governed by their commercial license. Abnormal cells are found in the lower part of the epidermis (the outer layer of the skin). copied without the express written consent of the AHA. Vulval (or vulvar) intraepithelial neoplasia is a pre-cancerous skin lesion (a type of squamous cell carcinoma in situ) that can affect any part of the vulva . Billing and Coding articles typically include CPT/HCPCS procedure codes, ICD-10-CM diagnosis codes, as well as Bill Type, Revenue, and CPT/HCPCS Modifier codes. Copyright 2023. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. The submitted medical record must support the use of the selected ICD-10-CM code(s). If the diagnostic term in the pathology report is not in the list below, be sure to consult your ICD-O manual. recipient email address(es) you enter. CPT codes, descriptions and other data only are copyright 2022 American Medical Association. ICD-9-CM Coding Chapter 2 of the ICD-9-CM contains the . Verrucous Carcinoma: Diagnosis, Treatment, Symptoms & Pathology Information. . The code lists in the article help explain which services (procedures) the related LCD applies to, the diagnosis codes for which the service is covered, or for which the service is not considered reasonable and necessary and therefore not covered. NON-MELANOMA SKIN CANCER Includes Basal Cell, Squamous Cell and required field. apply equally to all claims. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Response to Comment (RTC) articles list issues raised by external stakeholders during the Proposed LCD comment period. Any questions pertaining to the license or use of the CPT should be addressed to the AMA. Subject to the terms and conditions contained in this Agreement, you, your employees and agents are authorized to use CDT only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. The scope of this license is determined by the AMA, the copyright holder. If your session expires, you will lose all items in your basket and any active searches. As in ICD-9-CM, there is a separate Table of Neoplasms. When verrucous carcinoma forms on your feet, they manage it as a skin cancer. About 90% of cases of head and neck cancer (cancer of the mouth, nasal cavity, nasopharynx, throat and associated structures) are due to SCC.. The submitted CPT/HCPCS code must describe the service performed. Applicable Federal Acquisition Regulation Clauses (FARS)/Department of Defense Federal Acquisition Regulation supplement (DFARS) Restrictions Apply to Government Use. PDF Coding of Neoplasms in ICD-10-CM - AAPC In a few cases, such as for malignant melanoma and certain . On a Friday at monthend theCenters for Medicare 38 Medicaid Services CMS Proton therapy has been a tough sell for payers but recent 25 million Oklahoma decision against Aetna may make them reconsider coverage for the spreading radiation therapy technique. This type of excision would be most appropriately reported using the excision of malignant lesion including margins codes 11600- 11646. Key words: No portion of the American Hospital Association (AHA) copyrighted materials contained within this publication may be Consequently, solar UVR-induced skin cancers are among the most common forms of occupational malignancies that are potentially expected globally. Local Coverage Articles are a type of educational document published by the Medicare Administrative Contractors (MACs). Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. Healthcare providers are granted even more latitude for use of telehealth services during the COVID19 public health emergency. A Draft article will eventually be replaced by a Billing and Coding article once the Proposed LCD is released to a final LCD. By clicking below on the button labeled "I accept", you hereby acknowledge that you have read, understood and agreed to all terms and conditions set forth in this agreement. Medicare contractors are required to develop and disseminate Articles. C44.12- Squamous cell carcinoma of skin of eyelid, including canthus The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. Carcinoma In situ. 604 0 obj <> endobj The Medicare program provides limited benefits for outpatient prescription drugs. not endorsed by the AHA or any of its affiliates. This is the American ICD-10-CM version of C44.52 - other international versions of ICD-10 C44.52 may differ. In most instances Revenue Codes are purely advisory. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. Should the foregoing terms and conditions be acceptable to you, please indicate your agreement and acceptance by clicking below on the button labeled "I Accept". Making copies or utilizing the content of the UB‐04 Manual, including the codes and/or descriptions, for internal purposes, HPV-related oropharyngeal squamous cell carcinoma (OPSCC) is associated with a favorable prognosis, yet patients of color and low socioeconomic status (SES) continue to experience inferior outcomes. apply equally to all claims. These materials contain Current Dental Terminology (CDTTM), copyright© 2022 American Dental Association (ADA). Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (, malignant neoplasm of skin of genital organs (, Primary malignant neoplasm of skin of left shoulder, Primary malignant neoplasm of skin of left upper limb. of every MCD page. Federal government websites often end in .gov or .mil. Articles often contain coding or other guidelines that are related to a Local Coverage Determination (LCD). You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials. on Squamous Cell Carcinoma ICD-10-CM Coding, Tech & Innovation in Healthcare eNewsletter, Excision of Benign or Malignant Skin Lesion, Healthcare Finance Newsday: "AHIMA, AHA back move to ICD-10 as other groups cite high costs", AAPC to Host 17th Annual National Conference in Las Vegas in April 2009, Portability Issues Give PHRs a Rocky Start, Dome-shaped or crusty lesion that may bleed, Flat, reddish, scaly patch that grows slowly, Blue or green eyed people with blond or red hair, Long-term daily sun exposure, as with people that work outdoors with no sun protection or covering up, Older age. Squamous Cell Carcinoma ICD-10-CM Coding - AAPC Knowledge Center . Oct 2, 2018. However, services performed for any given diagnosis must meet all of the indications and limitations stated in the LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules. If you are experiencing any technical issues related to the search, selecting the 'OK' button to reset the search data should resolve your issues. Therefore, if a drug is self-administered by more than 50 percent of Medicare beneficiaries, the drug is excluded from coverage" and the MAC will make no payment for the drug. Primary malignant neoplasms overlapping site boundaries. descriptions may not be removed, copied, or utilized within any software, product, service, solution or derivative work If your session expires, you will lose all items in your basket and any active searches. C44.82 Squamous cell carcinoma of overlapping sites of skin The American Hospital Association ("the AHA") has not reviewed, and is not responsible for, the completeness or accuracy of any information contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material, or the analysis of information provided in the material. Cutaneous squamous-cell carcinoma is the second most common skin cancer, accounting for over 1 million cases in the United States each year.. Thyroid []. GOVERNMENT AND ITS EMPLOYEES ARE NOT LIABLE FOR ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION, PRODUCT, OR PROCESSES All neoplasms are classified in this chapter, whether they are functionally active or not. (ajcc 6th and 7th eds.). Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes. The medical record/progress note should indicate the removal of a malignant lesion with a corresponding pathology report or a clinical description consistent with a skin malignancy. (based on ajcc cancer staging). DISCLOSED HEREIN. Instructions for enabling "JavaScript" can be found here. Squamous cell carcinoma in situ - VisualDx In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. This Agreement will terminate upon notice if you violate its terms. These codes can be used for all HIPAA-covered transactions. authorized with an express license from the American Hospital Association. CPT is a trademark of the American Medical Association (AMA). Signs and symptoms of SCCs include: Squamous cell carcinoma is most commonly seen in fair-skinned people who have spent extended time in the sun. an effective method to share Articles that Medicare contractors develop. An official website of the United States government. The AMA does not directly or indirectly practice medicine or dispense medical services. The submitted CPT/HCPCS code must describe the service performed. If you would like to extend your session, you may select the Continue Button. Another option is to use the Download button at the top right of the document view pages (for certain document types). In this context, annotation back-references refer to codes that contain: Short description: Squamous cell carcinoma skin/ upper limb, including shoulder, This is the American ICD-10-CM version of. Privacy Policy | Terms & Conditions | Contact Us. The term vulval intraepithelial neoplasia describes two conditions with different biological behaviour: usual type and differentiated type. This section shows you chapter-specific coding guidelines to increase your understanding and correct usage of the target ICD-10-CM Volume 1 code. The size and location of the lesion must be included in the documentation. However, services performed for any given diagnosis must meet all of the indications and limitations stated in the LCD, the general requirements for medical necessity as stated in CMS payment policy manuals, any and all existing CMS national coverage determinations, and all Medicare payment rules. Refer to the LCD for reasonable and necessary requirements and limitations. ICD-10-CM Codes that Support Medical Necessity, ICD-10-CM Codes that DO NOT Support Medical Necessity, L33813 - Destruction of Malignant Skin Lesions, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), TRUNK, ARMS OR LEGS; LESION DIAMETER OVER 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), SCALP, NECK, HANDS, FEET, GENITALIA; LESION DIAMETER OVER 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 0.5 CM OR LESS, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 0.6 TO 1.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 1.1 TO 2.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 2.1 TO 3.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER 3.1 TO 4.0 CM, DESTRUCTION, MALIGNANT LESION (EG, LASER SURGERY, ELECTROSURGERY, CRYOSURGERY, CHEMOSURGERY, SURGICAL CURETTEMENT), FACE, EARS, EYELIDS, NOSE, LIPS, MUCOUS MEMBRANE; LESION DIAMETER OVER 4.0 CM, Malignant neoplasm of overlapping sites of palate, Malignant neoplasm of palate, unspecified, Malignant neoplasm of overlapping sites of unspecified parts of mouth, Malignant neoplasm of overlapping sites of other parts of mouth, Malignant melanoma of unspecified eyelid, including canthus, Malignant melanoma of right upper eyelid, including canthus, Malignant melanoma of right lower eyelid, including canthus, Malignant melanoma of left upper eyelid, including canthus, Malignant melanoma of left lower eyelid, including canthus, Malignant melanoma of unspecified ear and external auricular canal, Malignant melanoma of right ear and external auricular canal, Malignant melanoma of left ear and external auricular canal, Malignant melanoma of unspecified part of face, Malignant melanoma of other parts of face, Malignant melanoma of other part of trunk, Malignant melanoma of unspecified upper limb, including shoulder, Malignant melanoma of right upper limb, including shoulder, Malignant melanoma of left upper limb, including shoulder, Malignant melanoma of unspecified lower limb, including hip, Malignant melanoma of right lower limb, including hip, Malignant melanoma of left lower limb, including hip, Malignant melanoma of overlapping sites of skin, Merkel cell carcinoma of unspecified eyelid, including canthus, Merkel cell carcinoma of right upper eyelid, including canthus, Merkel cell carcinoma of right lower eyelid, including canthus, Merkel cell carcinoma of left upper eyelid, including canthus, Merkel cell carcinoma of left lower eyelid, including canthus, Merkel cell carcinoma of unspecified ear and external auricular canal, Merkel cell carcinoma of right ear and external auricular canal, Merkel cell carcinoma of left ear and external auricular canal, Merkel cell carcinoma of unspecified part of face, Merkel cell carcinoma of other parts of face, Merkel cell carcinoma of other part of trunk, Merkel cell carcinoma of unspecified upper limb, including shoulder, Merkel cell carcinoma of right upper limb, including shoulder, Merkel cell carcinoma of left upper limb, including shoulder, Merkel cell carcinoma of unspecified lower limb, including hip, Merkel cell carcinoma of right lower limb, including hip, Merkel cell carcinoma of left lower limb, including hip, Merkel cell carcinoma of overlapping sites, Other specified malignant neoplasm of skin of lip, Basal cell carcinoma of skin of right upper eyelid, including canthus, Basal cell carcinoma of skin of right lower eyelid, including canthus, Basal cell carcinoma of skin of left upper eyelid, including canthus, Basal cell carcinoma of skin of left lower eyelid, including canthus, Squamous cell carcinoma of skin of right upper eyelid, including canthus, Squamous cell carcinoma of skin of right lower eyelid, including canthus, Squamous cell carcinoma of skin of left upper eyelid, including canthus, Squamous cell carcinoma of skin of left lower eyelid, including canthus, Other specified malignant neoplasm of skin of right upper eyelid, including canthus, Other specified malignant neoplasm of skin of right lower eyelid, including canthus, Other specified malignant neoplasm of skin of left upper eyelid, including canthus, Other specified malignant neoplasm of skin of left lower eyelid, including canthus, Basal cell carcinoma of skin of right ear and external auricular canal, Basal cell carcinoma of skin of left ear and external auricular canal, Squamous cell carcinoma of skin of right ear and external auricular canal, Squamous cell carcinoma of skin of left ear and external auricular canal, Other specified malignant neoplasm of skin of right ear and external auricular canal, Other specified malignant neoplasm of skin of left ear and external auricular canal, Basal cell carcinoma of skin of other parts of face, Squamous cell carcinoma of skin of other parts of face, Other specified malignant neoplasm of skin of nose, Other specified malignant neoplasm of skin of other parts of face, Basal cell carcinoma of skin of scalp and neck, Squamous cell carcinoma of skin of scalp and neck, Other specified malignant neoplasm of skin of scalp and neck, Basal cell carcinoma of skin of other part of trunk, Squamous cell carcinoma of skin of breast, Squamous cell carcinoma of skin of other part of trunk, Other specified malignant neoplasm of anal skin, Other specified malignant neoplasm of skin of breast, Other specified malignant neoplasm of skin of other part of trunk, Basal cell carcinoma of skin of right upper limb, including shoulder, Basal cell carcinoma of skin of left upper limb, including shoulder, Squamous cell carcinoma of skin of right upper limb, including shoulder, Squamous cell carcinoma of skin of left upper limb, including shoulder, Other specified malignant neoplasm of skin of right upper limb, including shoulder, Other specified malignant neoplasm of skin of left upper limb, including shoulder, Basal cell carcinoma of skin of right lower limb, including hip, Basal cell carcinoma of skin of left lower limb, including hip, Squamous cell carcinoma of skin of right lower limb, including hip, Squamous cell carcinoma of skin of left lower limb, including hip, Other specified malignant neoplasm of skin of right lower limb, including hip, Other specified malignant neoplasm of skin of left lower limb, including hip, Basal cell carcinoma of overlapping sites of skin, Squamous cell carcinoma of overlapping sites of skin, Other specified malignant neoplasm of overlapping sites of skin, Malignant neoplasm of peripheral nerves of head, face and neck, Malignant neoplasm of peripheral nerves of unspecified upper limb, including shoulder, Malignant neoplasm of peripheral nerves of right upper limb, including shoulder, Malignant neoplasm of peripheral nerves of left upper limb, including shoulder, Malignant neoplasm of peripheral nerves of unspecified lower limb, including hip, Malignant neoplasm of peripheral nerves of right lower limb, including hip, Malignant neoplasm of peripheral nerves of left lower limb, including hip, Malignant neoplasm of peripheral nerves of thorax, Malignant neoplasm of peripheral nerves of abdomen, Malignant neoplasm of peripheral nerves of pelvis, Malignant neoplasm of peripheral nerves of trunk, unspecified, Malignant neoplasm of overlapping sites of peripheral nerves and autonomic nervous system, Malignant neoplasm of connective and soft tissue of head, face and neck, Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of right upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of left upper limb, including shoulder, Malignant neoplasm of connective and soft tissue of unspecified lower limb, including hip, Malignant neoplasm of connective and soft tissue of right lower limb, including hip, Malignant neoplasm of connective and soft tissue of left lower limb, including hip, Malignant neoplasm of connective and soft tissue of thorax, Malignant neoplasm of connective and soft tissue of abdomen, Malignant neoplasm of connective and soft tissue of pelvis, Malignant neoplasm of connective and soft tissue of trunk, unspecified, Malignant neoplasm of overlapping sites of connective and soft tissue, Malignant neoplasm of head, face and neck, Malignant neoplasm of unspecified upper limb, Malignant neoplasm of unspecified lower limb, Malignant neoplasm of other specified ill-defined sites, Melanoma in situ of unspecified eyelid, including canthus, Melanoma in situ of right upper eyelid, including canthus, Melanoma in situ of right lower eyelid, including canthus, Melanoma in situ of left upper eyelid, including canthus, Melanoma in situ of left lower eyelid, including canthus, Melanoma in situ of unspecified ear and external auricular canal, Melanoma in situ of right ear and external auricular canal, Melanoma in situ of left ear and external auricular canal, Melanoma in situ of unspecified part of face, Melanoma in situ of breast (skin) (soft tissue), Melanoma in situ of unspecified upper limb, including shoulder, Melanoma in situ of right upper limb, including shoulder, Melanoma in situ of left upper limb, including shoulder, Melanoma in situ of unspecified lower limb, including hip, Melanoma in situ of right lower limb, including hip, Melanoma in situ of left lower limb, including hip, Carcinoma in situ of skin of unspecified eyelid, including canthus, Carcinoma in situ of skin of right upper eyelid, including canthus, Carcinoma in situ of skin of right lower eyelid, including canthus, Carcinoma in situ of skin of left upper eyelid, including canthus, Carcinoma in situ of skin of left lower eyelid, including canthus, Carcinoma in situ of skin of unspecified ear and external auricular canal, Carcinoma in situ of skin of right ear and external auricular canal, Carcinoma in situ of skin of left ear and external auricular canal, Carcinoma in situ of skin of unspecified part of face, Carcinoma in situ of skin of other parts of face, Carcinoma in situ of skin of scalp and neck, Carcinoma in situ of skin of unspecified upper limb, including shoulder, Carcinoma in situ of skin of right upper limb, including shoulder, Carcinoma in situ of skin of left upper limb, including shoulder, Carcinoma in situ of skin of unspecified lower limb, including hip, Carcinoma in situ of skin of right lower limb, including hip, Carcinoma in situ of skin of left lower limb, including hip, Some older versions have been archived.